46 related articles for article (PubMed ID: 17125770)
1. Inhibition of the formation of amyloid beta-protein fibrils using biocompatible nanogels as artificial chaperones.
Ikeda K; Okada T; Sawada S; Akiyoshi K; Matsuzaki K
FEBS Lett; 2006 Dec; 580(28-29):6587-95. PubMed ID: 17125770
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein aggregation by zwitterionic polymer-based core-shell nanogels.
Rajan R; Matsumura K
Sci Rep; 2017 Apr; 7():45777. PubMed ID: 28374820
[TBL] [Abstract][Full Text] [Related]
3. Correction to "Oxytocin Nanogels Inhibit Innate Inflammatory Response for Early Intervention in Alzheimer's Disease".
Ye C; Cheng M; Ma L; Zhang T; Sun Z; Yu C; Wang J; Dou Y
ACS Appl Mater Interfaces; 2024 Jun; ():. PubMed ID: 38889098
[No Abstract] [Full Text] [Related]
4. Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective.
Nayab DE; Din FU; Ali H; Kausar WA; Urooj S; Zafar M; Khan I; Shabbir K; Khan GM
J Nanobiotechnology; 2023 Dec; 21(1):477. PubMed ID: 38087359
[TBL] [Abstract][Full Text] [Related]
5. Nanogels as novel drug nanocarriers for CNS drug delivery.
Manimaran V; Nivetha RP; Tamilanban T; Narayanan J; Vetriselvan S; Fuloria NK; Chinni SV; Sekar M; Fuloria S; Wong LS; Biswas A; Ramachawolran G; Selvaraj S
Front Mol Biosci; 2023; 10():1232109. PubMed ID: 37621994
[TBL] [Abstract][Full Text] [Related]
6. The unhappy chaperone.
Linse S; Thalberg K; Knowles TPJ
QRB Discov; 2021; 2():e7. PubMed ID: 37529680
[TBL] [Abstract][Full Text] [Related]
7. Self-Therapeutic Nanomaterials: Applications in Biology and Medicine.
Seaberg J; Clegg JR; Bhattacharya R; Mukherjee P
Mater Today (Kidlington); 2023; 62():190-224. PubMed ID: 36938366
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative disorders: Assessing the impact of natural vs drug-induced treatment options.
Mathur S; Gawas C; Ahmad IZ; Wani M; Tabassum H
Aging Med (Milton); 2023 Mar; 6(1):82-97. PubMed ID: 36911087
[TBL] [Abstract][Full Text] [Related]
9. The application of nanotechnology in treatment of Alzheimer's disease.
Cao Y; Zhang R
Front Bioeng Biotechnol; 2022; 10():1042986. PubMed ID: 36466349
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Review of Cross-Linked Gels as Vehicles for Drug Delivery to Treat Central Nervous System Disorders.
Mashabela LT; Maboa MM; Miya NF; Ajayi TO; Chasara RS; Milne M; Mokhele S; Demana PH; Witika BA; Siwe-Noundou X; Poka MS
Gels; 2022 Sep; 8(9):. PubMed ID: 36135275
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease.
Unnisa A; Greig NH; Kamal MA
Curr Med Chem; 2023; 30(3):255-270. PubMed ID: 35345990
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms Involved in Microglial-Interceded Alzheimer's Disease and Nanocarrier-Based Treatment Approaches.
Md S; Alhakamy NA; Alfaleh MA; Afzal O; Altamimi ASA; Iqubal A; Shaik RA
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834468
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine: A Promising Way to Manage Alzheimer's Disease.
Khan NH; Mir M; Ngowi EE; Zafar U; Khakwani MMAK; Khattak S; Zhai YK; Jiang ES; Zheng M; Duan SF; Wei JS; Wu DD; Ji XY
Front Bioeng Biotechnol; 2021; 9():630055. PubMed ID: 33996777
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders.
Vissers C; Ming GL; Song H
Adv Drug Deliv Rev; 2019 Aug; 148():239-251. PubMed ID: 30797953
[TBL] [Abstract][Full Text] [Related]
15. Nanogels as potential drug nanocarriers for CNS drug delivery.
Vashist A; Kaushik A; Vashist A; Bala J; Nikkhah-Moshaie R; Sagar V; Nair M
Drug Discov Today; 2018 Jul; 23(7):1436-1443. PubMed ID: 29775669
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine applications in women's health: state of the art.
Lloyd-Parry O; Downing C; Aleisaei E; Jones C; Coward K
Int J Nanomedicine; 2018; 13():1963-1983. PubMed ID: 29636611
[TBL] [Abstract][Full Text] [Related]
17. Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives.
Zhang T; Yang R; Yang S; Guan J; Zhang D; Ma Y; Liu H
Drug Deliv; 2018 Nov; 25(1):278-292. PubMed ID: 29334800
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.
Ahmad J; Akhter S; Rizwanullah M; Khan MA; Pigeon L; Addo RT; Greig NH; Midoux P; Pichon C; Kamal MA
Curr Alzheimer Res; 2017; 14(11):1164-1181. PubMed ID: 28482786
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles.
Tao X; Xie Y; Zhang Q; Qiu X; Yuan L; Wen Y; Li M; Yang X; Tao T; Xie M; Lv Y; Wang Q; Feng X
Nanomaterials (Basel); 2016 Sep; 6(9):. PubMed ID: 28335293
[TBL] [Abstract][Full Text] [Related]
20. Glyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity.
Kouyoumdjian H; Zhu DC; El-Dakdouki MH; Lorenz K; Chen J; Li W; Huang X
ACS Chem Neurosci; 2013 Apr; 4(4):575-84. PubMed ID: 23590250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
